Welcome to day 2 of ALK Summit 2021: STRONGER TOGETHER and keynote speaker, Tasneeem Ahmed talks about where the ALK space is today and the HOPE we have for the future with Q&A from the ALK Community. WATCH VIDEO
ALK Positive Inc.
Authors: Amanda Nerstad, Bill Westlake and Tasneem Ahmed
Read MoreALK Summit 2021: STRONGER TOGETHER: Research Funded by ALK Positive- Hear From the Researchers Mark Awad, Trever Bivona, Roberto Chiarle, Ibiayi Dagogo- Jack, Juston Gainor, John Iafrate, Christine Lovly, Raphael Nemenoff. Moderators: Colin Barton and Emily Venanzi WATCH VIDEO
ALK Positive Inc.
Authors: Mark Awad, Trever Bivona, Roberto Chiarle, Ibiayi Dagogo- Jack, Juston Gainor, John Iafrate, Christine Lovly and Raphael Nemenoff
Read MoreALK Summit 2021: STRONGER TOGETHER. What is Next After Lorlatinib? 4th Generation TKI’s and Beyond Speakers: dr. Ross Camidge, MD, PHD University of Colorado Cancer Center, Dr. Christine Lovly, MD PhD, BA Vanderbilt- Ingram Cancer Center. Moderator(s): Colin Barton, Emily Vennzi. Dr. Ross Camidge and Dr. Christine Lovly speak about the many treatment options that are available NOW if a patient experiences progression on Lorlatinib. Even more exciting, they speak about what's already visible on the horizon for new treatments that could transform our future. WATCH VIDEO
ALK Positive Inc.
Authors: Dr. Ross Camidge and Dr. Christine Lovly
Read MoreALK summit 2021: Benefits of a Multi-Disciplinary Team: Stronger Together Dr. Ross Camidge, MD, PhD University of Colorado Cancer Center, Dr. Vicent Lam, MDAssistant Professor of Oncology, Johns Hopkins University, Dr. Drew Maghanaki, MD, MPH, UCLA Department of Radiation Oncology, Dr. Brendon Stiles, MD, Professor and Chief of Thoracic Surgery Oncology Montefiore Health System, Dr. Laura Petrilo, MD, Palliative Care at Massachusetts General Hospital Moderator: Amanda Nerstad, ALK Summit Chair. WATCH VIDEO
ALK Positive Inc.
Authors: Dr. Ross Camidge, Dr. Vicent Lam, Dr. Drew Maghanaki, Dr. Brendon Stiles, Dr. Laura Petrilo and Amanda Nerstad
Read More
